FUNDAMENTALS
EdgeFII/DII
KIMSKrishna Inst Of MED SCI L
₹795.60+3.62%
Terminal
  • Overview
  • Price
  • Ratios
  • About
  • P&L
  • Balance
  • Cash flow
  • Holders
  • Actions
  • Peers
  • News
KIMSNSE · EquityHealthcare Services

Krishna Inst Of MED SCI L

ISIN
INE967H01025
Instrument key
NSE_EQ|INE967H01025
Open in terminal Fundamentals cached for 6 hours
Last traded price
₹795.60+27.80 · +3.62%
Day rangecircuit ₹636.50 – ₹954.70
760.70
801.50

as of 21/11/2026, 5:48:18 pm

Open
₹764.35
Day high
₹801.50
Day low
₹760.70
Prev. close
₹767.80
Volume
10.44 L
VWAP
₹789.81

On this page

Company

  • Overview
  • Price chart
  • Key ratios
  • About

Statements

  • Profit & loss
  • Balance sheet
  • Cash flow

Ownership

  • Shareholding
  • Corporate actions
  • Peers

Market

  • News

02/Price history

Price chart

1 year · daily candles. Hover the chart for the OHLC of any candle; the table below holds the same data row by row.

1D1W1M6M1Y5YMAX
Change · 1Y
+18.73%
670.10 → 795.60
Period high
₹858.00
6/7/2026
Period low
₹575.80
27/1/2026
From high
-7.27%
+38.17% from low
Avg volume
5.04 L
12.51 Cr total
Volatility · ann.
31.9%
248 candles · 114 up / 133 down
20 Nov 2026O 764.35H 801.50L 760.70C 795.60Vol 10.44 L
SMA 20SMA 50Averages need 50 candles before they begin
Candle data248 rows of open, high, low, close and volumeShowHide
20 Nov 2026764.35801.50760.70795.60+4.09%40.8010.44 L
19 Nov 2026754.05770.00754.05767.80+1.82%15.951.97 L
18 Nov 2026770.00772.15750.75759.00-1.43%21.402.76 L
17 Nov 2026770.00777.00753.75768.30-0.22%23.252.88 L
16 Nov 2026727.50767.90722.65763.35+4.93%45.2510.97 L
13 Nov 2026725.00736.00720.05729.65+0.64%15.952.70 L
12 Nov 2026726.15730.35717.05727.30+0.16%13.305.40 L
11 Nov 2026732.00732.00721.00726.15-0.80%11.001.45 L
9 Nov 2026734.90735.45718.45721.65-1.80%17.001.77 L
8 Nov 2026723.00739.00720.80734.70+1.62%18.2039.7K

Historical price and volume data · Showing 1–10 of 248

1 / 25

03/Valuation & returns

Key ratios vs sector

Company value benchmarked against the sector median. The ratio set is sector specific — banks report NIM, CASA and Net NPA instead of EV/EBITDA.

P/E

Price ÷ earnings per share

169.98
Company
169.98
Sector
55.28

Worse than sector by 207%

P/B

Price ÷ book value per share

8.52
Company
8.52
Sector
3.05

Worse than sector by 179%

ROA

Net income ÷ total assets

2.21%
Company
2.21%
Sector
4.2%

Worse than sector by 47%

ROE

Net income ÷ shareholders' equity

5.4%
Company
5.4%
Sector
-31.98%

Better than sector by 117%

ROCE

EBIT ÷ capital employed

7.29%
Company
7.29%
Sector
11.89%

Worse than sector by 39%

Quick Ratio

Liquid assets ÷ current liabilities

0.68
Company
0.68
Sector
32.98

Worse than sector by 98%

EV/EBITDA

Enterprise value ÷ EBITDA

37.8
Company
37.8
Sector
23.22

Worse than sector by 63%

04/Business

About the company

Sector: Healthcare Services

Krishna Institute of Medical Sciences Ltd is an India-based company, which is principally engaged in the business of rendering medical and healthcare services. The Company’s departments include accident, Alzheimer center, andrology and infertility center, pediatric obesity, pediatric oncology and hematology center, pediatric orthopedics and rheumatology, pediatric renal center, pediatric surgical center, female urology center, fertility center, gastrointestinal oncology, general surgery, heart wellness center, hepatobiliary surgery center, and others. Its medical technologies include 4-Arm HD da Vinci Robotic Surgical System, O-Arm Scanner, Novalis Tx Linear Accelerator, 3 Tesla MRI, EBUS, Spy Glass, Mako Robotic for Knee Replacement, Impella, and others. The Company’s institutes include the Institute of Cardiac Sciences, Institute of Dental Science, Institute of Gastroenterology & Hepatology, Institute of Heart & Lung Transplantation, among others.

Sector market cap (INR)
₹33,483 Cr

reported in crore

Sector market cap (USD)
$3.72B

reported in billion

Market capitalisation is reported at the sector-constituent level, not the standalone company level.

05/Profit & loss

Standalone income statement

Annual figures in ₹ crore. Growth marked reported is provided; margins are derived.

YearlyQuarterly
ConsolidatedStandalone
Revenue · Mar 2026
₹1,758 Cr
+22.02% vs Mar 2025
Net profit · Mar 2026
₹261 Cr
-13.93% vs Mar 2025
Operating margin
20.1%
was 28.0%
Revenue CAGR · 4p
15.0%
profit 1.1% · op 1.5%
Filed order
Revenue1,7581,4411,2401,156
Revenue growthreported22.0%16.2%7.3%—
Operating profit353403318337
Operating profit growthreported-12.5%26.7%-5.7%—
Operating marginderived20.1%28.0%25.7%29.2%
Net profit261303235252
Net profit growthreported-13.9%28.7%-6.8%—
Net marginderived14.8%21.0%19.0%21.9%
EPS — basic₹/share, annual6.527.575.8831.55

Figures in ₹ crore. Margin rows are computed from the reported values.

Full annual line itemsRevenue, other income, expenses, tax, EPSShowHide
Filed order
Revenue1,7021,3841,2221,132
Other Income57571824
Total Revenue1,7581,4411,2401,156
Total Expenses1,3981,049922819
Profit Before Tax353403318337
Tax921008385
Profit After Tax261303235252
EPS - Basic6.527.575.8831.55
EPS - Diluted6.527.575.8831.55

This breakdown is available annually, even when the summary above is quarterly. EPS rows are per share.

06/Balance sheet

Standalone balance sheet

Only annual balance sheets are available — the quarterly filter does not apply here. Figures in ₹ crore; net worth is assets minus liabilities.

ConsolidatedStandalone
Total assets · Mar 2026
₹4,285 Cr
+34.37% YoY
Total liabilities
₹1,856 Cr
Net worth
₹2,429 Cr
Liabilities ÷ assets
43.3%
lower means a lighter balance sheet
Filed order
Total assets4,2853,1892,3971,812
Total liabilities1,8561,021530181
Net worthderived2,4292,1681,8661,631
Liabilities ÷ assetsderived43.3%32.0%22.1%10.0%
Asset growthderived34.4%33.1%32.3%—

Figures in ₹ crore. Stacked chart height equals total assets.

Full annual line itemsNon-current & current assets, liabilities, equity capitalShowHide
Filed order
Non-Current Assets3,8512,8902,0951,575
Current Assets434299301237
Total Assets4,2853,1892,3971,812
Current Liabilities565359209120
Net Current Asset-131-5992117
Non-Current Liabilities1,29266232162
Equity Capital2,4292,1681,8661,631
Total Equity & Liabilities4,2853,1892,3971,812

Figures in ₹ crore unless the line item is per-share.

07/Cash flow

Standalone cash flow

Annual only, in ₹ crore. Negative values are outflows, so healthy companies usually show positive operating and negative investing cash flow.

ConsolidatedStandalone
Operating · Mar 2026
₹293 Cr
-0.37% YoY
Investing
-₹956 Cr
Financing
₹662 Cr
Free cash flow
-₹663 Cr
operating + investing
Filed order
Operating activities293294262271
Operating changereported-0.4%11.9%-3.2%—
Investing activities-956-627-569-238
Investing changereported-52.5%-10.2%-139.2%—
Financing activities662339289-15
Financing changereported95.6%17.3%2006.2%—
Net cash flowderived-16-1818
Free cash flowoperating + investing-663-333-30633

Figures in ₹ crore.

Full annual line itemsProfit before tax through closing cash balanceShowHide
Filed order
Profit before tax353403318337
Income before WC changes468427366363
Change in Assets-135-62-44-16
Change in Liabilities391926-2
Change in WC-96-43-18-17
Cash flow from Operations293294262271
Cash flow from Investing-956-627-569-238
Cash flow from Financing662339289-15
Total Cash Flow-16-1818
Cash (Start of the year)26213820
Cash (End of the year)25262138

Figures in ₹ crore unless the line item is per-share.

08/Ownership

Shareholding pattern

Percentage of total shares by holder category across the last 4 reported quarters. Sort any quarter column to rank holders by size.

Promoters
32.66%
+0.16 pts QoQ
FII
15.01%
+0.27 pts QoQ
DII (other)
4.09%
-1.82 pts QoQ
Mutual funds
28.21%
-0.31 pts QoQ
Retail & others
20.03%
+1.70 pts QoQ
Filed order
Promoters32.7%32.5%34.1%34.1%
FII15.0%14.7%14.6%14.3%
DII (other)4.1%5.9%5.1%5.2%
Mutual funds28.2%28.5%27.4%27.5%
Retail & others20.0%18.3%18.8%18.9%
Promoters — QoQ changepts, derived0.2%-1.6%0.0%—
FII — QoQ changepts, derived0.3%0.2%0.2%—
DII (other) — QoQ changepts, derived-1.8%0.8%-0.1%—
Mutual funds — QoQ changepts, derived-0.3%1.1%-0.1%—
Retail & others — QoQ changepts, derived1.7%-0.5%-0.0%—
Totalderived100.0%100.0%100.0%100.0%

Values are percentages of total outstanding shares; QoQ rows are percentage-point moves.

09/Events

Corporate actions

Dividends, bonuses, splits and rights issues. Filter by type, sort by any date, and expand a row for the full event detail.

No corporate actions on record

10/Comparison

Peers & competitors

Competitor set priced live. Filter by sector, sort any column, and expand a peer for its business description.

Sector
APOLLOHOSPApollo Hospitals Enter. LHealthcare Services₹9,200.00+5.29%14.13 L₹1,32,139 Cr$14.68B
MAXHEALTHMAX Healthcare INS LtdHealthcare Services₹1,081.00+3.88%95.32 L₹1,05,080 Cr$11.68B
MANIPALHOSManipal Health Enterpri LHealthcare₹702.20+0.83%11.62 L₹92,366 Cr$10.26B
ASTERDMAster DM Quality Care LtdHealthcare Services₹779.30+5.41%26.66 L₹67,960 Cr$7.55B
FORTISFortis Healthcare LtdHealthcare Services₹825.00+1.87%22.88 L₹62,284 Cr$6.92B
MEDANTAGlobal Health LimitedHealthcare Services₹1,480.20+0.13%2.65 L₹39,829 Cr$4.43B
NHNarayana Hrudayalaya Ltd.Healthcare Services₹1,945.00+3.84%7.85 L₹39,757 Cr$4.42B
LALPATHLABDR. LAL Path Labs Ltd.Healthcare Services₹1,989.00+1.31%2.65 L₹33,680 Cr$3.74B
SYNGENESyngene International LtdDiversified₹451.70+3.28%25.58 L₹18,240 Cr$2.03B
MOLBIOMolbio Diagnostics LtdHealthcare₹1,495.50-2.02%7.01 L₹17,228 Cr$1.91B

Market cap is the sector-constituent figure reported per peer · Showing 1–10 of 10

1 / 1

11/Coverage

Company news

Articles published in the last seven days, paginated by the provider.

5102050
  • Thumbnail: Max Healthcare, Apollo Hospitals, other healthcare stocks surge over 5% despite volatile market; what’s behind the surge?
    yesterday20/11/2026, 11:17:17 am
    Max Healthcare, Apollo Hospitals, other healthcare stocks surge over 5% despite volatile market; what’s behind the surge?

    Healthcare stocks like Apollo Hospitals and Max Healthcare, among others, were witnessing buying momentum in an overall volatile market on Friday, November 20, as investors focused on the constructive outlook despite the selling pressure from the global markets.

Showing 1–1 of 1 article